We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
European Marketing Authorization For Abilify - For Severe Manic Episodes In Bipolar I Disorder
Bipolar On April 8, 2008, the European Commission made a decision to allow thedrug ABILIFYŽ (aripiprazole) to be marketed. ABILIFY treats moderate tosevere manic episodes for patients with Bipolar I Disorder and it isdesigned to prevent new manic episodes in patients who experiencepredominately manic episodes.Before this decision, the European Committee for Medicinal Products forHuman Use (CHMP) issued a positive opinion in mid-February 2008.
Custom Search
